1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Norway >
  5. Balchem Acquires Kappa Bioscience

M&A Deal Summary

Balchem Acquires Kappa Bioscience

On June 14, 2022, Balchem acquired life science company Kappa Bioscience

Acquisition Highlights
  • This is Balchem’s 1st transaction in the Life Science sector.
  • This is Balchem’s 1st transaction in Norway.

M&A Deal Summary
Date 2022-06-14
Target Kappa Bioscience
Sector Life Science
Buyer(s) Balchem
Deal Type Add-on Acquisition

Target

Kappa Bioscience

Oslo, Norway
Kappa Bioscience is a science-based manufacturer of specialty vitamin K2 for the human nutrition industry. The company's discoveries include: The synthesis of pure, all-bioactive vitamin K2 MK-7, an essential vitamin needed to direct calcium around our bodies and keep hearts, bones, and lots of other things healthy. Today, that pioneering spirit is still as strong as ever. With patented processes, innovative technology, and renowned expertise, Kappa Bioscience AS produces K2VITAL and K2VITAL Delta; vitamin K2 with unmatched purity and stability, in a wider range of formulations than anyone else, to bring the best possible benefits of vitamin K2 to everyone. From vitamin K2 and turn-key solutions to research and marketing initiatives, to product launches and growth strategies, Kappa Bioscience AS believes in doing it right. That means developing products and services that set new standards of excellence, made with integrity, and through close collaboration. Kappa Bioscience was formed in 2006 and is based in Hamburg, Germany.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Balchem

Montvale, New Jersey, United States
Category Company
Founded 1967
Sector Chemicals
Employees1,301
Revenue 954M USD (2024)
DESCRIPTION

Balchem develops, manufactures, and sells specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. Balchem was founded in 1967 and is based in Montvale, New Jersey.

DEAL STATS #
Overall 6 of 7
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 6 of 7
Country: Norway M&A 1 of 1
Year: 2022 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-02 Chemogas NV

Grimbergen, Belgium

Chemogas NV is a provider of packaged chemical gases and related services. Chemogas also supplies natural refrigerant gases (like ammonia and propylene) and other specialty gases. Chemogas NV is one of the premier global providers of packaged Ethylene oxide to the medical sterilization industry, with exports to more than 70 countries.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-30 Bergstrom Nutrition

Vancouver, Washington, United States

Bergstrom Nutrition is a science-based manufacturer of methylsulfonylmethane (MSM). MSM is a widely used nutritional ingredient with strong scientific evidence supporting its benefits for joint health, sports nutrition, skin and beauty, healthy aging, and pet health. Bergstrom Nutrition is based in Vancouver, Washington.

Buy -
Mergr

Solution for

Product

Company

Legal